Haemonetics Corp Q2 FY2021 Earnings Call

Haemonetics Corp (HAE)

Earnings Call FY2021 Q2 Call date: 2020-11-04 Concluded

Quarter scorecard

Revenue

$209.49M

-17.1% YoY

Diluted EPS

$0.94

+30.6% YoY

Gross margin

50.5%

+0.2 pp YoY

Net income

$48.10M

+28.3% YoY

Plasma Products and Services $97.71M

-28.1%

Blood Center Products and Services $59.23M

-9.7%

Hospital Products and Services $52.54M

+2.8%